Mr. Marcílio D'Amigo Pousada has been the Chief Executive Officer of Raia Drogasil S.A. since July 1, 2013 and serves as its Member of Executive Board. Mr. Pousada serves as the Chief Executive Officer of...

取締役

名称	ポジション	在職期間	報酬	所有権
Plinio Musetti	Director	no data	データなし	データなし
Carlos Oliveira Dias	Director	30.7yrs	データなし	データなし
Renato Oliveira Dias	Director	22.7yrs	データなし	データなし
Paulo Coutinho Galvão Filho	Director	30.7yrs	データなし	0.69% R$ 305.8m
Antonio Pipponzi	Chairman of the Board	no data	データなし	1% R$ 441.7m
Cristiana Pipponzi	Director	11.4yrs	データなし	0.94% R$ 416.4m
Eugênio De Zagottis	Director	no data	データなし	0.81% R$ 358.6m
Marco Ambrogio Bonomi	Independent Director	no data	データなし	データなし
Sylvia de Leao Wanderley	Independent Director	no data	データなし	データなし
Philipp Paul Povel	Independent Director	no data	データなし	データなし
Denise Soares Santos	Independent Director	no data	データなし	データなし
Eduardo Azevedo de Alvarenga	Independent Director	no data	データなし	データなし

26.7yrs

平均在職期間

63yo

平均年齢

経験豊富なボード: RADL3の取締役会は経験豊富で経験豊富です ( 26.4年の平均在任期間)。

Raia Drogasil マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

Raia Drogasil S.A., Annual General Meeting, Apr 17, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Returns Are Gaining Momentum At Raia Drogasil (BVMF:RADL3)

Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

With Raia Drogasil S.A. (BVMF:RADL3) It Looks Like You'll Get What You Pay For

Now 20% overvalued

Upcoming dividend of R$0.049 per share

Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly

Does Raia Drogasil (BVMF:RADL3) Deserve A Spot On Your Watchlist?

Full year 2023 earnings released

Investors Met With Slowing Returns on Capital At Raia Drogasil (BVMF:RADL3)

Raia Drogasil S.A., Annual General Meeting, Apr 17, 2024

Raia Drogasil S.A.'s (BVMF:RADL3) Earnings Haven't Escaped The Attention Of Investors

Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?

Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?

Returns On Capital At Raia Drogasil (BVMF:RADL3) Have Stalled

Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?

Raia Drogasil S.A. to Report Q3, 2023 Results on Oct 31, 2023

Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?

Second quarter 2023 earnings: Revenues exceed analyst expectations

Here's What To Make Of Raia Drogasil's (BVMF:RADL3) Decelerating Rates Of Return

Is Raia Drogasil (BVMF:RADL3) Using Too Much Debt?

Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Upcoming dividend of R$0.048 per share at 0.9% yield

Returns At Raia Drogasil (BVMF:RADL3) Appear To Be Weighed Down

The Raia Drogasil S.A. (BVMF:RADL3) Yearly Results Are Out And Analysts Have Published New Forecasts

Full year 2022 earnings: EPS exceeds analyst expectations

Is Raia Drogasil (BVMF:RADL3) A Risky Investment?

Raia Drogasil S.A. to Report Q4, 2022 Results on Mar 07, 2023

Returns On Capital At Raia Drogasil (BVMF:RADL3) Have Hit The Brakes

Here's Why Raia Drogasil (BVMF:RADL3) Has Caught The Eye Of Investors

Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly

Less than half of directors are independent

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Raia Drogasil S.A. to Report Q3, 2022 Results on Oct 31, 2022

Raia Drogasil (BVMF:RADL3) Could Be Struggling To Allocate Capital

Here's Why Raia Drogasil (BVMF:RADL3) Has Caught The Eye Of Investors

Is Raia Drogasil (BVMF:RADL3) A Risky Investment?

Second quarter 2022 earnings: Revenues miss analyst expectations

Raia Drogasil S.A. to Report Q2, 2022 Results on Jul 29, 2022

There Are Reasons To Feel Uneasy About Raia Drogasil's (BVMF:RADL3) Returns On Capital

With EPS Growth And More, Raia Drogasil (BVMF:RADL3) Is Interesting

Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Less than half of directors are independent

Raia Drogasil S.A. to Report Q1, 2022 Results on May 03, 2022

Full year 2021 earnings: EPS misses analyst expectations

Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?

These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well

Raia Drogasil S.A. to Report Q4, 2021 Results on Feb 22, 2022

Some Investors May Be Worried About Raia Drogasil's (BVMF:RADL3) Returns On Capital

Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?

Third quarter 2021 earnings released

These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well

Returns On Capital At Raia Drogasil (BVMF:RADL3) Paint A Concerning Picture

Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?

Second quarter 2021 earnings released

These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well

First quarter 2021 earnings released

Raia Drogasil (BVMF:RADL3) Will Will Want To Turn Around Its Return Trends

Earnings beat expectations, revenue disappoints

Full year 2020 earnings released

We Think Raia Drogasil (BVMF:RADL3) Can Stay On Top Of Its Debt

New 90-day low: R$23.85

Raia Drogasil S.A. (BOVESPA:RADL3) signed a contract to acquire B2U Editora S.A.

Do Institutions Own Raia Drogasil S.A. (BVMF:RADL3) Shares?

Raia Drogasil S.A. to Report Q4, 2020 Results on Mar 09, 2021

Is Raia Drogasil S.A.'s (BVMF:RADL3) Recent Performance Tethered To Its Attractive Financial Prospects?

You Have To Love Raia Drogasil S.A.'s (BVMF:RADL3) Dividend

Did Business Growth Power Raia Drogasil's (BVMF:RADL3) Share Price Gain of 253%?

Is Raia Drogasil (BVMF:RADL3) A Risky Investment?

New 90-day high: R$27.03

マネジメント基準チェック /14